GENinCode Plc (LON:GENI – Get Free Report) shares dropped 6.5% on Friday . The stock traded as low as GBX 7.05 ($0.09) and last traded at GBX 7.25 ($0.09). Approximately 202,278 shares traded hands during trading, a decline of 33% from the average daily volume of 304,165 shares. The stock had previously closed at GBX 7.75 ($0.10).
GENinCode Stock Down 6.5 %
The company has a market capitalization of £12.83 million, a PE ratio of -120.83 and a beta of 0.40. The company’s 50 day moving average is GBX 5.79 and its two-hundred day moving average is GBX 5.99. The company has a quick ratio of 15.89, a current ratio of 5.92 and a debt-to-equity ratio of 6.74.
GENinCode Company Profile
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Featured Articles
- Five stocks we like better than GENinCode
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3 Stocks Leading the U.S. Agriculture Comeback
- High Dividend REITs: Are They an Ideal Way to Diversify?
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
